Document is current
Any future updates will be listed below
-
Authors
Chen, Yi https://orcid.org/0000-0002-7887-0175
Guo, Lei
Qin, Rui
Xi, Nan
Wang, Shengfu
Ma, Yujie
Ni, Xinli https://orcid.org/0000-0002-2857-1951
-
Funding
Funding for this research was provided by:
Ningxia Natural Science Foundation (2022AAC03591)
Ningxia Health System Fund for Scientific Research (2022-NWKY-056)
- License Information
-
More Information
Article History
Accepted: 7 April 2024
First Online: 13 June 2024
Declarations
:
: This work was supported by the Ningxia Natural Science Foundation (grant number: 2022AAC03591) and the Ningxia Health System Fund for Scientific Research (grant number: 2022-NWKY-056), Yinchuan, China.
: Yi Chen, Lei Guo, Rui Qin, Nan Xi, Shengfu Wang, Yujie Ma, and Xinli Ni have no conflicts of interests that are directly relevant to the content of this article.
: The local General Hospital Institutional Review Board (IRB #2020-943; Principal investigator: Yi Chen; 21 September, 2020) at Ningxia Medical University (Yinchuan, China) provided approval for this prospective, double-blind, randomized, controlled dose-finding trial.
: Written informed consent was provided by all participants prior to study entry.
: Not applicable.
: Data can be made available on reasonable request to the corresponding author.
: Not applicable.
: YC, LG, QR, SFW, and YJM collected the data. All authors contributed to the interpretation of the data and the development, writing, and approval of the manuscript.
